Solute clearance approach to adequacy of peritoneal dialysis

Peritoneal Dialysis International

Volumn 16, Issue 5, 1996, Pages 457-470

  Burkart, John M ^a   Schreiber, Martin ^b   Korbet, Stephen M ^c   Churchill, David N ^d   Hamburger, Richard J ^e   Moran, John ^f   Soderbloom, Robert ^g   Nolph, Karl D ^h  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d ST JOSEPH S HOSPITAL   (Canada)

^e INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^f BAXTER HEALTHCARE CORPORATION   (United States)

^g LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF MISSOURI   (United States)

Author keywords

Adequacy; Creatinine clearance; KT V; Nutrition; Patient survival

Indexed keywords

CREATININE;

ARTICLE; CREATININE CLEARANCE; HUMAN; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029858432     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600508     Document Type: Article

References (80)

1. Popovich RP, Moncrief JW, Decherd JB, et al. The definition of a novel portable/wearable equilibrium peritoneal dialysis technique (Abstract).ASAIO Trans 1976; 5:64.
2. Nolph KD. What's new in peritoneal dialysis - an overview. Kidney Int 1992; 42(Suppl 38):S148-52.
3. US Renal Data System. USRDS 1992 report. The National Institute of Health, National Institute of Diabetes and Digestive Diseases, Bethesda, Maryland, 1992:34.
4. Diaz-Buxo JA. CCPD is even better than CAPD. Kidney Int 1985; 28(Suppl 17):S26-8.
5. Twardowski ZJ, Nolph ED, Khanna R,et al. Peritoneal dialysis modifications to avoid CAPD dropouts. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1987; 3:171-8.
6. Teehan BP, Schleifer CR, Brown JM., et al.Urea kinetic analysis and clinical outcome on CAPD. A five-year longitudinal study. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1990; 6:181-5.
7. Blake PG, Sombolos K, Abraham G, et al. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 1991; 39:700-6.
8. Blake PG, Balaskas E, Blake R, et al. Urea has limited relevance in assessing adequacy of dialysis in CAPD. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1992; 8:65-70.
9. Blake PG, Balaskas I, Izatt S, et al. Is total creatinine clearance a good predictor of clinical outcome? Perit Dial Int 1992; 12:353-8.
10. Brandes JC, Piering WF, Beres JA. A method to assess efficacy of CAPD: preliminary report of results. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1990; 6:192-6.
11. Maiorca R, Brunori G, Zubani R,et al. Predictive value of dialysis and nutritional indices for morbidity and mortality in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10:2295-305.
12. Lameire NH, Vanholder R, Veyt D, et al. A longitudinal, five year survey of urea kinetic modeling parameters in CAPD patients. Kidney Int 1992; 42:426-32.
13. De Alvaro F, Bajo MA, Alverez-Ude F, et al. Adequacy of peritoneal dialysis: does Kt/V have the same predictive value as in HD? Amulticenter study. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1992; 8:93-7.
14. Churchill DN, Taylor DW, Keshaviah PR. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7:198-207.
15. Genestier S, Hedelin G, Schaffer P, et al. Prognostic factors in CAPD patients: a retrospective study of a 10 year period. Nephrol Dial Transplant 1995; 10:1905-11.
16. Teehan BP, Schliefler CR, Sigler MH, et al. A quantitative approach to CAPD prescription. Perit Dial Bull 1985; 5:152-6.
17. Keshaviah PK, Nolph KD, Van Stone JC. The peak urea concentration hypothesis: a urea kinetic modeling approach to comparing adequacy of continuous peritoneal dialysis and hemodialysis. Perit Dial Int 1989, 9:257-60.
18. Keshaviah P. Adequacy of CAPD: a quantitative approach. Kidney Int 1992; 42(Suppl 38):S160-4.
19. Teehan BP, Schleifler CR, Brown J. Urea kinetic modeling is an appropriate assessment of adequacy. Semin Dial 1992; 5:189-92.
20. Canadian Organ Replacement Register. 1993 annual report. Canadian Institute for Health Information, Don Mills, Ontario, March, 1995.
21. US Renal Data System. USRDS 1994 annual report. The National Institute of Health, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland, 1994.
22. Tattersall JE, Doyle S, Greenwood RN,et al. Maintaining adequacy of dialysis in CAPD by individualizing the dialysis prescription. Nephrol Dial Transplant 1994; 7:749-52.
23. Keshaviah PK, Ma J, Thorpe K, et al. Comparison of 2 year survival on hemodialysis (HD) and peritoneal dialysis with dose of dialysis matched using the peak concentration hypothesis (Abstract).J Am Soc Nephrol 1995; 6:540.
24. Acchiardo SR, Kraus AP, Kaufman PA,et al. Evaluation of CAPD prescription. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1991; 7:47-50.
25. Chen HH, Shetty A, Afthentopoulos IE, et al. Discrepancy between weekly KT/V and weekly creatinine clearance in patients on CAPD. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1995; 11:83-7.
26. Vonesh EF, Burkart JM, McMurray SD, Williams PF. Peritoneal Dialysis kinetic modeling: validation in a multicenter clinical study. Perit Dial Int 1996; 16:471-81.
27. Nolph KD, Twardowski ZJ, Keshaviah PR. Weekly clearances of urea and ereatinine on CAPD and NIPD. Perit Dial Int 1992; 12:298-303.
28. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements.Am J Clin Nutr 1980; 33:27-39.
29. Hume R, Weyers E. Relationship between total body water and surface area in normal and obese subjects. J Clin Pathol 1971; 24:234-8.
30. Jones MR. Etiology of severe malnutrition: results of an international cross-sectional study in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1994; 23:412-20.
31. Rottembourg J, Issad B, Gallego JL, et al. Evolution of residual renal function in patients undergoing maintenance hemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1993; 19:397-403.
32. Cancarini GC, Brunori G, Camerini C,et al. Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Bull 1986; 6:77-9.
33. Lysaght MJ, Vonesh EF, Gotch F,et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37:598-604.
34. Keshaviah P, Nolph KD, Prowant B. Defining adequacy of CAPD with urea kinetics. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1990; 6:173-7.
35. Rodby RA, Firanek CA, Cheng YG, et al. The reproducibility of studies of peritoneal dialysis adequacy. Kidney Int 1996; 50:267-71.
36. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7:95-108.
37. Pyle WK Mass transfer in peritoneal dialysis. Ph.D. diss, University of Texas, Austin, Texas, 1981.
38. Pannekeet MM, Imholz ALT, Struijk DG, et al. The standard permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48:866-75.
39. Keshaviah P, Emerson PF, Vonesh EF, et al. Relationship between body size, fill volume and mass transfer area coefficients in peritoneal dialysis.J Am Soc Nephrol 1994; 4:1820-3.
40. Jensen RA, Nolph KD, Moore HL, et al. Weight limitations for adequate therapy using commonly performed CAPD and NIPD regimens. Semin Dial 1994; 7:61-4.
41. Nolph KD. Has peritoneal dialysis peaked? The impact of the CANUSA study. ASAIO Trans 1996; 42:136-8.
42. Blake PG. Targets in CAPD and APD prescription.Perit Dial Int 1996; 16(Suppl):S143-6.
43. Young GA, Kopple JD, Lindholm B, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991; 17:462-71.
44. Kopple JD, Jones MR, Keshaviah PK,et al. A proposed glossary for dialysis kinetics. Am J Kidney Dis 1995; 26:961-81.
45. Keshaviah P, Nolph K Protein catabolic rate calculations in CAPD patients. ASAIO Trans 1991; 37:M400-2.
46. Randerson DH, Chapman GV, Farrell PC. Amino acid and dietary status in CAPD patients. In: Atkins RC, Thomson NM, Farrell PC, eds. Peritoneal dialysis. Edinburgh: Churchill Livingstone, 1981:171-91.
47. Usha K, Moore HL, Nolph KD. Protein catabolic rate in CAPD: comparison of different techniques. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1996; 12:284-7.
48. Van ItallieTB, YangMU, Heymsfield SB,et al. Height-normalized indices of the body's fat free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52:953-9.
49. Nolph KD, Moore HL, Prowant B, et al. Cross-sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993; 13:178-83.
50. Enia G, Sicuso C, Alati G, et al. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993; 8:1094-8.
51. Lo W-K, Prowant BF, Moore HL, et al. Comparison of different measurements of lean body mass in normal individuals and in chronic peritoneal dialysis patients. Am J Kidney Dis 1994; 23:74-85.
52. Keshaviah PK, Nolph KD, Moore HL, et al. Lean body mass estimated from creatinine kinetics. J Am Soc Nephrol 1994; 4:1475-84.
53. Detsky AJ, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11:8-13.
54. Hermann FR, Safran C, Levkoff SE,et al. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992; 152:125-30.
55. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15:458-82.
56. Rocco MV, Jordan JAR, Burkart JM. The efficacy number as a predictor of morbidity and mortality in peritoneal dialysis patients. J Am Soc Nephrol 1993; 4:1184-91.
57. Pollock CA, Ibels LS, Caterson RJ, et al. Continuous ambulatory peritoneal dialysis. Eight years of experience at a single center. Medicine 1989; 68:293-308.
58. Gamba G, Meijia JL, Saldivar S, et al. Death risk in CAPD patients. Nephron 1993; 65:23-7.
59. Blake PG, Plowerdew G, Blake R,et al. Serum albumin in patients on continuous ambulatory peritoneal dialysis - predictors of correlations with outcomes.J Am Soc Nephrol 1993; 3:1501-7.
60. Germain M, Harlow P, Mulhern J, et al. Low protein catabolic rate and serum albumin correlate with increased mortality and abdominal complications in peritoneal dialysis patients. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1992;113-15.
61. Nolph KD, Moore HL, Prowant B, et al. Continuous ambulatory peritoneal dialysis with a high flux membrane. ASAIO J 1993; 39:566-8.
62. Bergstrom J, Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int 1993; 43:S39-50.
63. Lindsay RM, Spanner E, Heidenheim RP, et al. Which comes first, Kt/V or PCR - chicken or egg? Kidney Int 1992; 42:S32-6.
64. Harty JC, Farragher B, Boulton H,et al. Is the correlation between normalized protein catabolic rate and Kt/V due to mathematic coupling? J Am Soc Nephrol 1993; 4:407.
65. Gotch F. A positive correlation of PCRN to KT/V in cross-sectional studies is not proof of a causal relationship. Perit Dial Int 1995; 15:274-5.
66. Harty J, Farragher B, Venning M, et al. Urea kinetic modeling exaggerates the relationship between nutrition and dialysis in CAPD patients. (The hazards of cross-sectional analysis), Perit Dial Int 1995; 15:105-9.
67. Tzamaloukas AH, Malhotra D, Murata GH, et al. Increasing the dose of CAPD and serum albumin (Abstract). Perit Dial Int 1995; 15(Suppl 4):S31.
68. Burkart JM, Rocco MV, Davis LG,et al. Total energy and dietary protein intake from 9 day food records are related to dialysis dose in PD and HD (Abstract). Perit Dial Int 1995; 15(Suppl 1):S37.
69. Heimburger O, Tranaeus A, Bergstrom J, et al. The effect of increased PD on Kt/V, protein catabolic rate (PCR) and serum albumin (Abstract). Perit Dial Int 1992; 12(Suppl):S19.
70. Jindal KK, Hirsch DJ. Long-term peritoneal dialysis in the absence of residual renal function. Perit Dial Int 1996; 16:77-89.
71. Rocco MV, Jordan JR, Burkart JM. Changes in peritoneal transport during the first month of peritoneal dialysis. Perit Dial Int 1995; 15:12-17.
72. Gotch F, Keen M. Kinetic modeling in peritoneal dialysis. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical dialysis. 3rd ed. East Norwalk, CT: Appleton & Lange, 1995.
73. Keen M, Lipps B, Gotch F. The measured creatinine generation rate in CAPD suggests only 78% of the prescribed dialysis is delivered. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1993; 9:73-5.
74. Burkart JM, Bleyer AJ, Jordan JR, et al. An elevated ratio of measured to predicted creatinine production in CAPD patients is not a sensitive predictor of noncompliance with the dialysis prescription. Perit Dial Int 1996; 16:142-6.
75. Nolph KD, Twardowski ZJ, Khanna R, et al. Predicted and measured daily creatinine production in CAPD: identifying noncompliance. Perit Dial Int 1995; 15:12-15.
76. Blake PG, Spanner E, MeMurray S, et al. Comparison of measured and predicted creatinine excretion is an unreliable index of compliance in PD patients. Perit Dial Int 1996; 16:147-53.
77. Tzamaloukas AH. Can an excess of estimated over predicted creatinine generation be a discriminating test for noncompliance in continuous ambulatory peritoneal dialysis? J Am Soc Nephrol 1995; 6:1519-20.
78. Caruana RJ, Smith KL, Hess CP, et al. Dialysate dumping: a novel cause of inadequate dialysis in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1989; 9:319-20.
79. Twardowski ZJ. Nightly peritoneal dialysis (why? who? annd when?) ASAIO Trans 1990; 36:8-16.
80. van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996; 7:745-50.